These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11852166)

  • 1. Regulatory approvals in a large multinational clinical trial: the ESPRIT experience.
    McNay LA; Tavel JA; Oseekey K; McDermott CM; Mollerup D; Bebchuk JD;
    Control Clin Trials; 2002 Feb; 23(1):59-66. PubMed ID: 11852166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Navigating the maze of requirements for obtaining approval of non-interventional studies (NIS) in the European Union.
    Ramirez I
    Ger Med Sci; 2015; 13():Doc21. PubMed ID: 26633964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory challenges associated with conducting multicountry clinical trials in resource-limited settings.
    Ndebele P; Blanchard-Horan C; Shahkolahi A; Sanne I
    J Acquir Immune Defic Syndr; 2014 Jan; 65 Suppl 1(0 1):S29-31. PubMed ID: 24321981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transitioning to the National Institutes of Health single institutional review board model: Piloting the use of the Streamlined, Multi-site, Accelerated Resources for Trials IRB Reliance.
    Vardeny O; Hernandez AF; Cohen LW; Franklin A; Baqai M; Palmer S; Bierer BE; Cobb N
    Clin Trials; 2019 Jun; 16(3):290-296. PubMed ID: 30866676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Working with the institutional review board.
    Byerly WG
    Am J Health Syst Pharm; 2009 Jan; 66(2):176-84. PubMed ID: 19139484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Institutional Review Boards: What Clinician Researchers Need to Know.
    Lapid MI; Clarke BL; Wright RS
    Mayo Clin Proc; 2019 Mar; 94(3):515-525. PubMed ID: 30832791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethical issues during the conduct of clinical trials.
    Silverman H
    Proc Am Thorac Soc; 2007 May; 4(2):180-4; discussion 184. PubMed ID: 17494728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons.
    Kodish E; Stocking C; Ratain MJ; Kohrman A; Siegler M
    J Clin Oncol; 1992 Nov; 10(11):1810-6. PubMed ID: 1403062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality assurance of ethical issues and regulatory aspects relating to good clinical practices in the HELENA Cross-Sectional Study.
    Béghin L; Castera M; Manios Y; Gilbert CC; Kersting M; De Henauw S; Kafatos A; Gottrand F; Molnar D; Sjöström M; Leclercq C; Widhalm K; Mesana MI; Moreno LA; Libersa C;
    Int J Obes (Lond); 2008 Nov; 32 Suppl 5():S12-8. PubMed ID: 19011647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficiency of single institutional review board review in National Institute of Child Health and Human Development Cooperative Reproductive Medicine Network-initiated clinical trials.
    Diamond MP; Eisenberg E; Huang H; Coutifaris C; Legro RS; Hansen KR; Steiner AZ; Cedars M; Barnhart K; Ziolek T; Thomas TR; Maurer K; Krawetz SA; Wild RA; Trussell JC; Santoro N; Zhang H;
    Clin Trials; 2019 Feb; 16(1):3-10. PubMed ID: 30354458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accreditation of ethics committees: experience of an ethics committee.
    Kulkarni R; Saraiya U
    Indian J Med Ethics; 2015; 12(4):241-5. PubMed ID: 26592789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs.
    Hata T; Nakamura K; Yonemori K; Noguchi E; Watanabe M; Sohn J; Lu YS; Yap YS; Tamura K; Fujiwara Y
    Clin Transl Sci; 2021 May; 14(3):1015-1025. PubMed ID: 33382914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the quality of human research protection programs to improve protection of human subjects participating in clinical trials.
    Tsan MF; Tsan LW
    Clin Trials; 2015 Jun; 12(3):224-31. PubMed ID: 25631384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs and inconsistencies in US IRB review of low-risk medical education research.
    Kano M; Getrich CM; Romney C; Sussman AL; Williams RL
    Med Educ; 2015 Jun; 49(6):634-7. PubMed ID: 25989411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Lugano statements on controlled clinical trials.
    Blum AL; Chalmers TC; Deutsch E; Koch-Weser J; Rosén A; Tygstrup N; Zentgraf R
    J Int Med Res; 1987; 15(1):2-22. PubMed ID: 3817279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical tips for working effectively with your institutional review board.
    Schwenzer KJ
    Respir Care; 2008 Oct; 53(10):1354-61. PubMed ID: 18812000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients come from populations and populations contain patients. A two-stage scientific and ethics review: The next adaptation for single institutional review boards.
    Knopman D; Alford E; Tate K; Long M; Khachaturian AS
    Alzheimers Dement; 2017 Aug; 13(8):940-946. PubMed ID: 28709585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical responsibilities toward indirect and collateral participants in pragmatic clinical trials.
    Smalley JB; Merritt MW; Al-Khatib SM; McCall D; Staman KL; Stepnowsky C
    Clin Trials; 2015 Oct; 12(5):476-84. PubMed ID: 26374687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human rights and ethical considerations in oral health research.
    Ellen RP; Singleton R
    J Can Dent Assoc; 2008 Jun; 74(5):439. PubMed ID: 18538067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.